Ir-6: A Novel Iridium (III) Organometallic Derivative for Inhibition of Human Platelet Activation

Platelet activation has been reported to play a major role in arterial thrombosis, cancer metastasis, and progression. Recently, we developed a novel Ir(III)-based compound, [Ir(Cp(∗))1-(2-pyridyl)-3-(4-dimethylaminophenyl)imidazo[1,5-a]pyridine Cl]BF(4) or Ir-6 and assessed its effectiveness as an...

Descripción completa

Detalles Bibliográficos
Autores principales: Shyu, Ren-Shi, Khamrang, Themmila, Sheu, Joen-Rong, Hsia, Chih-Wei, Velusamy, Marappan, Hsia, Chih-Hsuan, Chou, Duen-Suey, Chang, Chao-Chien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954965/
https://www.ncbi.nlm.nih.gov/pubmed/29853830
http://dx.doi.org/10.1155/2018/8291393

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5954965/
https://www.ncbi.nlm.nih.gov/pubmed/29853830
http://dx.doi.org/10.1155/2018/8291393

Ejemplares similares